CannaMD

DECEMBER 16, 2020

By joining, you will contribute to research that will help the consortium learn more about medical marijuana and improve the usefulness and safety for people who are using or considering using medical marijuana, just like yourself. Click the links below to browse condition-specific studies: ADHD. CannaMD ‘s got you covered!

Marijuana 119

Marijuana Epilepsy Treatment Safety 119

MMJ Recs

JUNE 25, 2024

Cannabis consumption for medical purposes has gained widespread acceptance in recent years, thanks to growing research supporting its efficacy in alleviating symptoms associated with numerous medical conditions. One of the key considerations when using cannabis for medical purposes is selecting the appropriate consumption method.

Consumption 52

Consumption Conditions Chronic Pain Tincture 52

The Cannigma

FEBRUARY 4, 2021

Instead of only approving synthetic versions, like it did with THC, in 2018 the FDA greenlighted cannabidiol (CBD) derived from the cannabis plant as an approved medicine — under the brand name Epidiolex — as a treatment for rare forms of childhood epilepsy. Put that in your pipe and smoke it. The Cannigma/Anthony Travagliante).

THC 145

THC Cannabinoids Blood Pressure Conditions 145

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. The perception that CBD is a wonder-drug version of cannabis — particularly known for its uses to treat epilepsy — that doesn’t get you high. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

United Patients Group

MAY 31, 2023

Cannabidiol, or CBD , has become a popular natural remedy for various health conditions. However, determining the right CBD dosage can be tricky, as numerous factors may affect its efficacy and safety. This article will review the key factors to help you find your ideal CBD dosage.

CBD 105

CBD Chronic Pain Sleep Conditions 105

The Cannigma

MARCH 7, 2022

CBN’s ability to target CB2 receptors, in comparison to THC (which prefers the CB1 receptor), gives it better credibility in treating autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. How much this conversation takes place is not yet well studied and would vary based on many conditions.

THC 139

THC Sleep Clinical Trials Cannabinoids 139

MMJ Recs

NOVEMBER 6, 2023

Best MMJ Strains in New York The availability of MMJ strains in New York has expanded over the years, offering patients a wider selection of options to address various medical conditions. New York’s Medical Cannabis Strains New York’s medical cannabis strains are carefully cultivated and regulated to ensure quality and safety.

Strains 105

Strains Chronic Pain Patients Dispensary 105

Veriheal

NOVEMBER 18, 2022

According to the Texas Department of Public Safety Chief Wayne Muller, the state has averaged a 10% month-over-month increase in medical cannabis patients over the last 18 months. In September, the state expanded its list of qualifying conditions , allowing veterans with PTSD and cancer patients to join the program.

Edibles 98

Edibles Hemp Epilepsy Programs 98

Leafwell

SEPTEMBER 25, 2020

However, as we have learned over the past several years, cannabis has been useful for many debilitating or life-threatening conditions, including childhood epilepsy, cancer, autism. For many, cannabis is seen as a recreational tool, and nothing more.

Epilepsy 81

Epilepsy Conditions Recreational Cannabis 81

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because cannabis is still a schedule 1 drug in the U.S.,

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.

Safety 52

Safety Cannabinoids Events Data 52

The Cannigma

APRIL 19, 2021

In recent years, lawmakers have eased up on a number of cannabis-derived formulations, and since 2015, people with epilepsy can obtain cannabis oil that contains less than 0.5% These products can be prescribed to a resident of the state by a medical physician that is qualified “with respect to a patient’s particular medical condition.”.

Law 84

Law Epilepsy Conditions Programs 84

WeedAdvisor

JULY 11, 2019

CBD proved to be life-changing for epilepsy patients, with some preliminary studies indicating that it could help with several other issues, like inflammation. However, there are many unanswered questions about the science, safety, and quality of products containing CBD.”. WeedAdvisor’s Commitment to Consumer Safety. .

CBD 76

CBD Epilepsy Safety Treatment 76

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

NOVEMBER 26, 2019

The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. This includes ongoing work to obtain and evaluate information to address outstanding questions related to the safety of CBD products, while maintaining the agency’s rigorous public health standards.

Safety 49

Safety Food CBD Oil 49

Cannabis Law Report

DECEMBER 3, 2021

Extended Duration Safety and Efficacy of Adjunctive Ganaxolone Treatment in Patients with CDKL5 Deficiency Disorder: 8-Month Minimum Open-Label Extension Follow-up. Safety findings from this OLE analysis are consistent with the safety in the double-blind phase as well as the known safety profile of gananxolone.

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. From its anti-inflammatory properties to its ability to alleviate pain, CBD shows promise in addressing various health conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

MJ Business Attorneys

OCTOBER 26, 2017

She came to the industry not from the recreational side, but as a mother seeking treatment for her child with epilepsy. In 2014, I was reading the Senate Bill 339 [Texas’ Compassionate Use Act enacted in 2015] testimony of mothers of children with epilepsy. Based on what I read on epilepsy I knew it had some success there.

Epilepsy 100

Epilepsy Recreational Treatment Programs 100

United Patients Group

AUGUST 28, 2023

In this comprehensive guide, United Patients Group , the leading source for patient information on medical marijuana, will explore the current state of research and knowledge on CBD for pets, touching on the potential benefits, safety considerations, and best practices for incorporating CBD products into a pet’s wellness regimen.

Pets 97

Pets CBD Chronic Pain Digestion 97

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

More than half the states in the country have now legalized medical cannabis for patients with qualifying conditions and several more have gone so far as to legalize recreational marijuana for adults. Children who suffer from these conditions generally experience social and developmental delays due to constant seizures.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Epilepsy Behav. Available at: www.fda.gov/media/131878/download.

CBD 144

CBD Seed-To-Sale Food Access 144

Canna Law Blog

JUNE 18, 2019

Second, the Committee focused on the safety of CBD itself. FDA-approved Epidiolex , the epilepsy medication that contains CBD, includes a warning about liver damage. These concerns echo the FDA’s statements on Hemp-CBD, especially the reference to unsubstantiated and misleading claims about CBD.

Hemp 90

Hemp CBD Food Research and Development 90

Leafwell

JANUARY 18, 2021

After all, research has shown that cannabis is effective in treating and managing symptoms for illnesses and conditions like anxiety, Alzheimer’s, chronic pain, eating disorders, epilepsy, and many, many more conditions besides. That’s awesome! So now that your card has come in the mail.

Chronic Pain 61

Chronic Pain Dispensary Epilepsy Conditions 61

Veriheal

JUNE 22, 2020

Born with neonatal hypoxic-ischemic encephalopathy, a condition characterized by a lack of oxygen or blood flow from the placenta, Oscar was at risk for seizures that might have led to brain injury. The priority was ensuring the health and safety of the baby. The doctors spent nine days monitoring the newborn’s condition closely.

Therapy 76

Therapy Treatment Research and Development Conditions 76

Otherside Farms

FEBRUARY 19, 2019

And with CBD supplements available for pets now, many dog owners tend to reasonably question their safety. Just like humans, dogs can suffer from various health conditions, such as epilepsy or arthritis. Not worsen your dog’s condition. Your pet’s condition will not lie. What Makes CBD Safe to Use.

Pets 15

Pets Oil Hemp CBD 15

PrestoDoctor

JULY 26, 2023

These properties have led to a growing interest in using CBD as a natural supplement for pets to alleviate various conditions such as pain , anxiety, inflammation, seizures, and more. Epilepsy is a common neurological disorder in pets, and traditional medications may come with unwanted side effects. This is simply not true.

Pets 96

Pets CBD Safety Blood Pressure 96

Veriheal

NOVEMBER 10, 2020

Despite the fact that there are still months before the start of this experiment, Nicolas Authier (chair of the French Agency for Safety of Medicines and Health Products, or ANSM) stated that France is now officially committed to giving citizens access to medical cannabis. .

Chronic Pain 90

Chronic Pain Pharmaceutical Patients Epilepsy 90

Otherside Farms

JANUARY 14, 2021

From chronic conditions to mental disorders, it is often presented as a viable solution for many difficult issues. Most importantly, how effective is it for specific conditions? It is Approved by the FDA for Helping With Epilepsy. Food and Drug Administration (FDA) approved a CBD-based oral solution in 2018 to treat epilepsy.

CBD 52

CBD Chronic Pain Epilepsy Consumption 52

MMJ Recs

MAY 25, 2024

Dysfunction in the ECS has been linked to a range of health conditions, highlighting its significance in maintaining overall physiological balance and promoting well-being. In these conditions, alterations in endocannabinoid signaling pathways may contribute to aberrant neuronal activity, neuroinflammation, and neurodegeneration.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

Veriheal

MAY 17, 2021

She ends the column by stating “ I urge our legislators to abandon this legislation for the sake of our citizen’s health and safety.”.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

Cannabis Law Report

FEBRUARY 17, 2020

In recent years, they have also reportedly proved their efficiency in treating cognitive issues like Alzheimer’s and Parkinson’s disease along with childhood epilepsies. Oxidative stress is a condition when our body’s natural antioxidants fail to neutralize all the free radicals, leading to neurological damages.

Oil 64

Oil CBD Blood Pressure Epilepsy 64

Veriheal

AUGUST 9, 2023

CBD, Trema micrantha, and the Study’s Significance CBD means cannabidiol , one of over a hundred compounds in the cannabis plant, and is widely celebrated as a potential treatment for a long list of health concerns, including chronic pain , epilepsy , i nsomnia , anxiety , and skin allergy.

CBD 96

CBD Cannabinoids THC Extraction 96

CannaMD

MAY 9, 2022

Marijuana legalization is often thought of in terms of its potential effects on crime, public safety, and tax revenue. But new research published in Health Economics suggests that there may be another significant outcome of legalization – a decrease in the demand for certain prescription drugs covered by state Medicaid programs.

Legalization 98

Legalization Marijuana Safety Programs 98

Healer

DECEMBER 17, 2021

The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. Glaucoma is still the first condition many people think of when they consider cannabis as a medicine.

CBD 98

CBD THC Conditions Medicine 98

Dykema (Cannabis Law Blog)

APRIL 20, 2023

[iii] The Act was originally intended for patients with intractable epilepsy and was expanded in 2019 and 2021 to include other physical and mental illnesses (cancer, multiple sclerosis, post-traumatic stress disorder). [iv] Health & Safety Code § 487.001 et seq. [iv] Specifically, H.B. Specifically, H.B. Code § 169.001 et seq. [vi]

Law 74

Law Chronic Pain Conditions Medicine 74

MMJ Recs

APRIL 3, 2024

In this blog, we’re looking at Ohio’s medical marijuana regulations , how to obtain a medical marijuana card, qualifying conditions, dispensaries, patient rights, caregiver requirements, doctor recommendations, possession limits, the application process, and recent updates in the laws.

Law 52

Law Marijuana Conditions Patients 52

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76